|
|
|
|
|
Product Name
|
Integrin beta 3 antibody [CRC54]
|
| |
See all Integrin beta 3 antibodies (29)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Mouse monoclonal [CRC54] to Integrin beta 3
|
|
Immunogen
|
Purified human gpIIIa/VNR beta-chain glycoprotein.
|
|
Reacts with
(species key)
|
Hu
|
|
Specificity
|
The antibody reacts with platelets and megakaryocytes. The antibody reacts preferentially with the activated/occupied form of platelet GPIIb-IIIa (ligand- induced biding site or LIBS epitope) and dissociated form of GPIIIa. This antibody does not react with platelets of patients with Glanzmann thrombastenia.
|
|
Epitope
|
The epitope is located within the N-terminal region of GPIIIa (first 100 amino acids).
|
|
Tested applications
(see key)
|
Flow Cyt, ICC/IF, IHC-Fr, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions Flow Cyt: Use at an assay dependent dilution. ICC/IF: Use at an assay dependent dilution. IHC-Fr: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. Predicted molecular weight: 87 kDa.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Cellular localization
|
Type I membrane protein
|
|
Research areas
|
Cardiovascular >> Atherosclerosis >> Hypertension >> Vascular remodelling >> Integrins Signal Transduction >> Cytoskeleton / ECM >> Cell Adhesion >> Integrins >> Beta Cardiovascular >> Blood >> Platelets Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Integrins
|
|
Relevance
|
Human Integrin beta 3 (CD61) antigen is a 90-110 kDa glycoprotein polypeptide which is expressed on platelets, megakaryocytes, macrophages, osteoclasts and synovial lining cells. The platelet glycoprotein is the integrin beta 3 chain of the vitronectin receptor and GPIIb/IIIa complex.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Mouse
|
|
Clonality
|
Monoclonal
|
|
Clone number
|
CRC54
|
|
Isotype
|
IgG1
|
|
Light chain type
|
kappa
|
|
Purity
|
IgG fraction
|
|
Storage buffer
|
Preservative: Sodium Azide Constituents: PBS Material safety datasheet (MSDS) for this product: Sodium Azide MSDS
|
|
Purification notes
|
Ammonium sulfate + DEAE-cellulose, gradient elution
|
|
Form
|
Liquid
|
|
Concentration
|
0.200 mg/ml
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Integrin beta 3 antibody [CRC54] is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
References for Integrin beta 3 antibody [CRC54] (ab34409)
|
|
This product has been used in: (two most recent references)
Alghisi GC et al. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 4:e4449 (2009). ICC/IF; Human. PubMed: 19212436
Reynolds AR et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 15:392-400 (2009). Flow Cyt; Human. PubMed: 19305413
See all 3 publication references for this product.
If you publish research using ab34409 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to Integrin beta 3
|
| |
Integrin beta 3 antibody [CRC54] - more information
|
Customer reviews (feedback) regarding Integrin beta 3 antibody [CRC54] |
Customer FAQs regarding Integrin beta 3 antibody [CRC54] |
Protocols for Integrin beta 3 antibody [CRC54] |
Price and availability of products related to Integrin beta 3 antibody [CRC54] |
| |
Integrin beta 3 antibody [CRC54] - related products:
|
|
|
| |
Integrin beta 3 antibody [CRC54] - other tools:
|
Contact Abcam with a Technical Enquiry about Integrin beta 3 antibody [CRC54] |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"